1. Home
  2. AMCI vs CRDL Comparison

AMCI vs CRDL Comparison

Compare AMCI & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AMCI

AMC Robotics Corporation Common Stock

N/A

Current Price

$4.87

Market Cap

153.4M

Sector

Finance

ML Signal

N/A

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.08

Market Cap

132.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMCI
CRDL
Founded
2021
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
153.4M
132.6M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
AMCI
CRDL
Price
$4.87
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
64.5K
372.3K
Earning Date
04-20-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$33.37
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.60
$0.88
52 Week High
$15.75
$1.71

Technical Indicators

Market Signals
Indicator
AMCI
CRDL
Relative Strength Index (RSI) 43.01 31.38
Support Level $4.10 $0.93
Resistance Level $5.77 $1.18
Average True Range (ATR) 0.50 0.06
MACD 0.04 -0.02
Stochastic Oscillator 42.39 1.75

Price Performance

Historical Comparison
AMCI
CRDL

About AMCI AMC Robotics Corporation Common Stock

AMC Robotics Corp is a technology solutions company that offers AI-powered smart security and robotics solutions. It currently sells smart hardware products designed for residential and commercial use, including smart cameras, driving recorders, action cameras, and Retina K cameras, which are marketed under the YI brand. AMC Robotics is also engaged in developing additional hardware products and technology capabilities, including IoT-enabled devices, AI-based features, wearable devices, and AI robotics. Using its technological capabilities, the company is developing robotic dogs, robotic arms, and robotic unloading systems, offering smart solutions for the logistics and warehousing sectors. It has two primary operating segments: North America, which generates maximum revenue, and Europe.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

Share on Social Networks: